Tag - medicine

 
 

MEDICINE

Japan Times
EDITORIALS
Dec 16, 2022
China’s reopening poses new challenges for itself and the world
The situation in China is likely to get worse with the ending of the 'zero-COVID' policy before it gets better, slowing its economy even more.
Japan Times
JAPAN / Science & Health
Dec 15, 2022
Despite unclear effectiveness, kanpō in short supply amid COVID wave
The widespread use and availability of kanpu014d in Japan has given some people hope that it may work as a viable treatment for the viral disease.
Japan Times
BUSINESS / Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Japan Times
JAPAN / Science & Health
Dec 13, 2022
Shionogi says Japan government to buy 1 million more COVID pill doses
The added supply agreement comes at a time when Japan is dealing with an eighth wave of COVID-19 infections.
Japan Times
BUSINESS
Dec 8, 2022
Ex-Theranos president Ramesh Balwani gets 13-year prison term in fraud case
Balwani and the company's founder, Elizabeth Holmes, had promised to revolutionize the medical industry by using a few drops of blood to complete a wide array of health tests.
Japan Times
WORLD / Science & Health
Dec 6, 2022
Long ICU stays lead to extended misery for many COVID survivors
The mechanical ventilation, anti-inflammatory drugs and other tools of modern medicine that help people beat severe cases of COVID-19 often come with harrowing aftereffects.
Japan Times
COMMENTARY / World
Dec 2, 2022
Amgen has a contender in the weight-loss drug wars
Amgen's obesity drug offers a new twist on proven methods to help people lose unwanted pounds.
Japan Times
BUSINESS / Companies
Nov 30, 2022
Japanese biotech firm uses tiny worms in test for pancreatic cancer
The creatures, a species of nematodes known scientifically as C. elegans, have olfactory senses much more powerful than dogs, the firm says, and they follow their nose toward cancer cells.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
Japan Times
WORLD / Science & Health
Nov 29, 2022
Scientists revive 48,500-year-old ‘zombie virus’ buried in ice
Scientists have long warned that the thawing of permafrost due to atmospheric warming will worsen climate change. But its effect on dormant pathogens is less well understood.
Japan Times
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
JAPAN
Nov 25, 2022
Human rights violations confirmed at leprosy sanatorium
According to the report, 1,674 residents died in the facility between 1938 and 1998, and autopsies were performed on 1,184 of them, about 70% of the total.
Japan Times
WORLD / Science & Health
Nov 25, 2022
Researchers test mRNA technology for universal flu vaccine
A universal vaccine would not mean an end to flu seasons, but would replace the guess work that goes into developing annual shots months ahead of flu season each year.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer’s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer's RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Japan Times
COMMENTARY / World
Nov 18, 2022
Why China won't cooperate on finding the origins of COVID-19
For Beijing, winning its u2018people's war' against the coronavirus by controlling the propaganda narrative is more important than learning the truth about the pandemic.
Japan Times
COMMENTARY / World
Nov 16, 2022
New weight-loss drugs work, but who's paying?
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren't yet on board.
Japan Times
COMMENTARY / World
Nov 15, 2022
Why China won’t end its 'COVID zero' policy
Chinese President Xi Jinping early on took ownership of the battle against the coronavirus — now his political legitimacy rests on the outcome.
Japan Times
JAPAN / FOCUS
Nov 14, 2022
Crowdfunding helping plug gap in government funding for academic research
The fundraising mechanism has also come into wider use in the nation's medical community, with some cases of research gathering pace after collecting large amounts of financial support.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?